IR Contact

Investor Relations And Corporate Communications

Temre Johnson

Director, Investor Relations and Corporate Communications
Mirati Therapeutics
858-332-3562
ir@mirati.com

Name *

Name is required

Email *

Email is required

Subject *

Subject is required

Comments *

Comments is required.



Enter the code shown above.
*

Validation Code is invalid.

Investor Contact

Temre Johnson

Investor Relations and Corporate Communications
Mirati Therapeutics
858-332-3562
ir@mirati.com

Quick Links

Investor FAQ's
Governance
SEC Filings

Investor Alerts

You may automatically receive Mirati Therapeutics, Inc. information by email.

NOTE: Re-select all alerts you would like to receive if you change your subscription preferences.

To opt-in for email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Mirati Therapeutics, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Mirati Therapeutics, Inc. to send you the requested Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News

Annual Reports

SEC Filings

End of Day Stock Quote